Celltrion Healthcare receives EC approval for the first high concentration, low-volume and citrate-free biosimilar adalimumab, Y admin Wed, 02/17/2021 - 16:50
source https://www.pharmatutor.org/content/february-2021/celltrion-healthcare-receives-ec-approval-for-the-first-high-concentration-low-volume-and-citrate-free-biosimilar-adalimumab-y
Subscribe to:
Post Comments (Atom)
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19...
-
Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute (THSTI) and ha...
No comments:
Post a Comment